DA-5204

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd., Seoul National University Hospital

Conditions

Acute GastritisChronic GastritisEsophageal Disease

Phase 3

A Study to Evaluate the Efficacy and Safety of DA-5204

Dong-A ST Co., Ltd.Acute Gastritis, Chronic Gastritis

Start: 2014-04-30End: 2014-11-30Updated: 2014-11-04

Efficacy of DA-5204 on Gastroesophageal Reflux Disease

CompletedNCT03998969

Seoul National University HospitalEsophageal Disease

Start: 2016-06-01End: 2018-12-11Updated: 2019-06-26

Related Papers

Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study

Journal of Korean Medical Science2017-01-0113 citations